AzTrials
AzTrials

Obstetric Anaesthesia With Cardiac ComplicationsNCT04989270

A Superior Anesthetic Technique for the Cesarean Section From a Hemodynamic Perspective.

An observational study of Obstetric Anaesthesia With Cardiac Complications, run by Sultan Qaboos University at 1 site in Oman.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cesarean section operations are increasing in rates worldwide. A proper anesthetic technique is required to maintain the safety of both the mother and the fetus. This study examines the adverse hemodynamic effects associated with general and regional anesthesia and proposes a superior technique from the hemodynamic… Read more about this study

Who is it for?
Ages 17 to 48 years, women only
What is being tested?
General Anesthesia and Regional Anesthesia
How many people
2,500 participants
Where
1 siteOman
Study dates
7 Jul 2020to 15 May 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 48 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Study population: All the patients who underwent Cesarean section under either type of Anesthesia, electively or in an emergency situation, with different indications, were included in the study.

Who may be able to join

  • All the patients that underwent CS in SQUH during the study period (Jan'2015 - Dec'2019)

Who cannot join

  • Patients with missing data

Trial locations and contacts

1 site in 1 country.

Oman1 site
  • Sultan Qaboos University Hospital

    Muscat, 123

Other trials in Oman

About this study

Official title: A Five-year Retrospective Study to Find a Superior Anesthetic Technique for the Cesarean Section From a Hemodynamic Perspective.

Cesarean section operations are increasing in rates worldwide. A proper anesthetic technique is required to maintain the safety of both the mother and the fetus. This study examines the adverse hemodynamic effects associated with general and regional anesthesia and proposes a superior technique from the hemodynamic perspective.

A retrospective cohort study with a five-year study period was conducted on patients who underwent cesarean section with general anesthesia (GA) and regional anesthesia (RA) after obtaining ethical committee approval. Data (hypotension, bradycardia, and blood loss) was collected from hospital information system records of the patients who underwent cesarean section from January 2015 to December 2019. The significance of the variables was determined using the Chi-square test.

A total of 2500 patients were studied. 1379 patients underwent cesarean section with RA meanwhile 1121 patients with GA.

Read the detailed description

Cesarean section Over the past few decades, cesarean section (CS) rates have been increasing tremendously; it is the most called for surgery in the obstetric department, for instance; in the US, there was an increase of CS by 14% from 1998 to 2001 with a 53% increase in elective primary CS rates and a 13% increase in medically advised primary CS rates (Alnour et al., 2015). The term primary CS is used when the operation is done for the first time on a pregnant patient (Saha and Chowdhury, 2011). This increase in CS rates can be explained by the increased demand for the comfort aspect during labor and the lifesaving properties of this operation in certain conditions for both the mother and the baby (Chen et al., 2019; Tadevosyan et al., 2019). A superior anesthetic method should ease surgical discomfort, decrease postoperative adverse effects, and should have excellent intraoperative analgesia (Alnour et al., 2015; Chen et al., 2019). An anesthetic is used to alleviate the pain of CS operation using either general (GA) or regional (RA) (spinal (SA) and epidural (EA)) anesthetics; sometimes, they can be used together (Alnour et al., 2015).

Pregnancy-induced hypotension The physiological changes associated with pregnancy and aortocaval compression or supine hypotension syndrome are the primary cause of hypotension during pregnancy (Mavridou et al., 2013). Aortocaval compression associated with natural pregnancy decreases cardiac output (CO) and venous return (VR). It starts at 20 weeks of gestation when the patient is lying flat in the supine position. Blood flow from the lower extremities will be disrupted and delayed from reaching the central circulation and the maternal heart; this happens due to the compression force applied by the uterus on the inferior vena cava and the abdominal aorta. This could restrain blood flow to the uterus, increases the risk of morbidity and mortality for both the mother and the fetus. Therefore, choosing a proper anesthetic technique that will not cause further hypotension during the process of CS is important (Mavridou et al., 2013; Alnour et al., 2015; Šklebar et al., 2019).

Anesthesia-induced hypotension There are two definitions of anesthesia-induced hypotension based on studies. It is a decrease to 80% from the baseline blood pressure value or a decrease of systolic arterial pressure (SAP) to <100 mm Hg. A report led in the UK in 1999 found that most expert obstetric anesthetists utilize a hypotension limit of either 100 or 90 mm Hg of SAP (Šklebar et al., 2019).

General anesthesia GA is either inhaled or injected, causing a state of unconsciousness carefully controlled. It is clinically useful due to its ability to induct rapidly, therefore useful in emergency situations. GA drugs can cross the placenta affecting the fetus. Furthermore, it was commonly believed that it could cause birth asphyxia. GA-induced hypotension was noted as 28% in participants in one study, with systolic and diastolic BP not notably contrasting with the SA group; however, it was more hemodynamically stable and had a minor impact on Apgar score along with umbilical cord blood gas. ICU admissions can happen due to hypotension in GA but less than SA (Alnour et al., 2015; Chen et al., 2019).

Regional anesthesia SA is given for a local anesthetic effect lasting for 2-3 hours; it is widely used. However, rejection by patients for this method is due to anxiety, tension, fear of visualizing the operating room environment, and the thought of being paralyzed. SA-induced hypotension was a research subject for more than 50 years (Alnour et al., 2015; Chen et al., 2019; Šklebar et al., 2019). The decrease in systemic vascular resistance (SVR), which is caused by loss of sympathetic tone in SA reduces CO and SVR. This effect will be compounded by fall in BP due to supine hypotension syndrome (Mavridou et al., 2013). The hypotension rate in SA significantly fluctuates between 7.4% and 74.1%, and in another study, 64% - 100% (Nikooseresht et al., 2016; Šklebar et al., 2019). Hypotension was noted as 48% of participants having CS under SA in a study in Libya (Alnour et al., 2015). Interestingly, it was reported by one of the studies that SA increased CO by 13%, with no significant changes observed in total peripheral resistance (TPR) or mean arterial pressure (MAP) (Ram et al., 2017). Hypotension was also seen in participants undergoing CS with techniques where both SA and EA were used together. (Chen et al., 2019). Prolonged SA-induced hypotension accompanied by decreased SAP can inadequately affect fetal circulation leading to fetal acidosis and hypoxia (Alnour et al., 2015; Šklebar et al., 2019).

There are no studies done to compare GA and RA specifically in terms of the hemodynamic perspective alone (Alnour et al., 2015; Šklebar et al., 2019). Therefore, the present study aimed to find a superior anesthetic technique from a hemodynamic standpoint and proposed a better technique for managing hemodynamic instabilities of pregnant patients undergoing CS.

Aim of this study To examine and find a better technique of anesthesia for the cesarean section from a hemodynamic perspective.

Specific objectives

  • To study adverse hemodynamic effects associated with general versus regional anesthetic techniques for cesarean section.
  • To propose a superior anesthetic technique from the hemodynamic perspective for cesarean section.

Methodology Setting and design A five-year retrospective cohort study on patients who underwent CS from 1st January 2015 to 31st December 2019 at Sultan Qaboos University Hospital (SQUH) in the Department of Anesthesia and Intensive care, after obtaining ethical approval from the Medical Research committee at SQUH in July 2020 (MREC #2178). The "TrakCare" hospital information system was used to acquire patients' demographic data.

Patients The inclusion criteria of this study were all the patients that underwent CS in SQUH during the study period, and the exclusion criteria were missing data. The sample size of this study included all the patients who underwent CS in this study period, as there were no prior similar studies to calculate the sample size from. A total of 2500 patients were included and coded for identity. This study was not based on any previous studies. Therefore, the population was regarded as all of the patients included in the study period.

Data collection The data was obtained from the hospital information system "TrakCare." Data like age, the urgency of surgery, and the type of anesthesia were all recorded before each surgery, along with the ASA physical status classification system grade. Intraoperative data included heart rate (HR) measured as beats per minute (bpm) and blood pressure (BP) measured as (mm Hg) were obtained from the anesthesia records in the attached Electronic Patient Record (EPR) documents. Blood loss measured in liters (L) and APGAR scores of newborns were also obtained from the surgery notes and clinical notes along with the use of vasopressor intraoperatively. Postoperative anesthesia-related complications were recorded along with the postoperative length of stay (Days) and the mortality of the mother and the baby.

Data analysis Data was collected, and the patient's identity was coded. Individual data coding was done and analyzed using Statistical Package for the Social sciences (SPSS) software (version23). Descriptive statistics were used to present the data. The Chi-Square test was used to determine the association between different variables under investigation with a p-value of <0.05 considered to be statistically significant. Continuous variables were suitably analyzed using means+/- SD. Missing data was ignored if the percentage of the missing data was less than 10%. The graphical representation tools of SPSS software such as bar charts, pie charts, and cross-tabulation were used to describe the analyzed data and present the categorized and uncategorized variables.

Being tested
General Anesthesia, Regional Anesthesia
Keywords
cesarean section, hemodynamics, general anesthesia, regional anesthesia, intraoperative complications, APGAR Score
Medical subject headings
Intraoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • General AnesthesiaProcedure or surgery

    General anesthesia with intubation, ventilation, intravenous and inhalational anesthetics, opioids and muscle paralysis

  • Regional AnesthesiaProcedure or surgery

    Spinal Anesthesia, Epidural Anesthesia

Study groups in NCT04989270
Study groupRoleWhat they receive
Patients undergoing Cesarean sectionGroup of patients undergoing Cesarean section between Jan'2015 to Dec'2019
Receives: Procedure: General Anesthesia; Procedure: Regional Anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of intraoperative hypotension

    Systolic Blood pressure less than 90 mm hg

    Measured: 2-3 hours

Secondary outcomes (2)
  1. Intraoperative blood loss

    Effect of type of Anesthesia or it's sequelae on Blood loss during Cesarean section

    Measured: 2-3 hours

  2. Impact on APGAR Score

    Effect of type of anesthsia or it's sequelae on foetal APGAR score

    Measured: 2-3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2021
  2. Study start7 Jul 2020
  3. Primary completion31 Mar 2021
  4. Study completion15 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
2,500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04989270
Sponsor's protocol ID
MREC#2178
Status last verified
May 2021
First submitted
5 Jul 2021
Last updated
4 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: There is a plan to make IPD and related data dictionaries available.

Questions about this trial

What is this clinical trial studying?

An observational study of Obstetric Anaesthesia With Cardiac Complications, run by Sultan Qaboos University at 1 site in Oman.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Oman. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of intraoperative hypotension (time frame: 2-3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in